Peptidomimetics: A New Frontier in Neurodegenerative Treatment

Neurotrophin Peptidomimetics: A New Hope for Neurodegenerative Disorders

Neurotrophin Peptidomimetics

A New Hope for Neurodegenerative Disorders

Understanding Neurodegenerative Diseases

Neurodegenerative diseases (NDs) pose a significant global health challenge. Neurotrophins, essential proteins for neuronal survival, have shown potential as treatments, but their instability limits their use.

The Promise of Peptidomimetics

Peptidomimetic drugs mimic natural proteins and can be repurposed to treat NDs by promoting neuronal growth and survival. They offer improved stability and bioavailability compared to endogenous neurotrophins.

Research Insights

Led by Prof. Ashis K. Mukherjee at IASST, researchers are exploring peptidomimetics to overcome the limitations of natural peptides. Their studies focus on signaling pathways and pharmacological targets for effective therapeutic applications.

Future Directions

As research progresses, peptidomimetics may become a key strategy in managing neurodegenerative disorders, with potential applications in other diseases like cancer.

Learn More

© 2023 Neurotrophin Research. All rights reserved.

Comments

Popular posts from this blog

Inauguration

India's Nationwide Civil Defence Mock Drill on May 7, 2025: What to Expect